IVUS Analysis for Coronary Obstruction in TAVI

Coronary Artery Occlusion Clinical Trial

— ICARO  

Official title:

Intravascular Ultrasound Assessment of Coronary Artery at High Risk for Obstruction Following TAVI

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05164796
• Other study ID #: ICARO
• Status: Recruiting
• Phase: N/A
• Start date: January 20, 2022
• Est. completion date: December 31, 2024

Study information

• Verified date: November 2022
• Source: Universita di Verona
• Contact: Flavio Ribichini, MD
• Phone: +39 045 812 2320
• Email: flavio.ribichini[@]univr.it
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Observational, prospective, single-arm and multi-center study to assess the safety and feasibility of IVUS imaging in the setting of TAVI and to describe the angiographic and intravascular ultrasound features in patients with coronary arteries deemed at high-risk for coronary artery obstruction following TAVI.

Description:

CHIMNEY stenting is a reasonable strategy to manage catastrophic coronary artery obstruction (CAO). However, this technique is frequently used, not for acute catastrophic CAO (clinically evident), but preventively because the operator believes that CAO may occur on complete transcatheter heart valve (THV) deployment or after the protective coronary guidewire is withdrawn (3/5 of cases). Consequently, in current clinical practice, many patients receive CHIMNEY stents that are not required, and thus incur the associated risks of this procedure. To date, operators do not know how many patients, among those underwent preventive CHIMNEY, really required stenting, or on the contrary, did not. Also, accordingly, a real estimation of CAO incidence is not possible, but is likely higher than that reported in previous studies. At present, no objective measures have been identified that could help operators decide when to deploy a CHIMNEY stent. If it could be demonstrated in the catheterization laboratory that the displaced native or bioprosthetic leaflets were sufficiently far away from the native coronary ostia and the risk for CAO was low, then unnecessary CHIMNEY stenting could be avoided. Angiographic images do not provide sufficient information to clarify that. The investigation of a coronary ostium at risk of CAO from an intravascular point of view may reveal the presence of the displaced leaflet in front of them, or on the other hand, its absence, supporting operators in the decision to stent or not to stent. In addition to the potential for IVUS to determine when CHIMNEY stenting should be used, this technique may also be used to optimize the results of CHIMNEY stenting when it has been deployed. Moreover, IVUS can also be used to assess the result of the BASILICA technique after leaflet laceration. The hypothesis is that the use of IVUS imaging for the assessment of patency of the coronary ostium and of the relationship of displaced valve leaflets towards the coronary arteries may reveal novel risk factors to predict which are not detectable by traditional angiography.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Age > 18 years

2. Written informed consent

3. Diagnosis of symptomatic severe aortic stenosis, or clinically relevant degeneration of previously implanted surgical aortic valve bioprosthesis

4. Patient undergoing TAVI according to local institutional protocol and following Heart Team discussion.

5. High-quality ECG gated computed tomography (CT) scan of the heart and aorta

6. Presence of 2 or more of the following risk factors for CAO (high-risk):

6a. TAVI in native valves: height of the coronary ostium (<9 mm), sinuses of Valsalva width <30 mm, leaflet tips extending above the coronary ostia or the sino-tubular junction. 6b. VIV-TAVI (patients undergoing BASILICA as first prevention strategy are also included): surgical bioprosthesis type: with supra-annular position, high leaflet profile, externally mounted leaflets stented valve, stentless valves, and bulky leaflets, low-lying coronary ostia (< 9 mm from the ostia to the sewing ring), narrow sinuses of Valsalva (<30 mm by width for Valsalva sinuses), virtual THV-coronary (VTC) distance <4 mm, virtual THV-STJ (VT-STJ) distance < 2.5-3.5 mm: to be considered in cases where VTC >4mm but the leaflet extends above or very close (up to 2mm below) to the STJ plane.

Exclusion Criteria:

1. Age < 18 years

2. Pregnancy

3. Absence of informed consent

4. Angiographic or functional critical stenosis of the at-risk coronary artery (%DS > 70 for right coronary artery, > 50 for left main, or positive functional assessment), requiring revascularization regardless the risk of CAO.

5. Signs or symptoms of acute (unstable) myocardial ischemia

6. Reduced survival expectancy due to severe co-morbidities (<1 year)

Related Conditions & MeSH terms

• Coronary Artery Occlusion
• Coronary Occlusion

Intervention

Device:
• IVUS assessment of coronary ostia
For coronary arteries at high-risk of obstruction during TAVI in native valves or valve-in-valve TAVI: IVUS analysis before valve implantation (+ coronary angiogram) to detect any leaflet interference with the coronary ostium, existing prior to the transcatheter heart valve (THV) placement IVUS analysis (+ coronary angiogram) after valve implantation in absence of acute coronary occlusion, to assess the patency of the ostium at-risk, the presence of native or degenerated surgical leaflet adjacent to the ostium, and the interaction of THV-frame with the coronary ostium. In case of CHIMNEY stenting, re-assessment of the stent expansion and coronary ostia patency with IVUS.

Locations

Country	Name	City	State
Italy	AOUI Verona	Verona

Sponsors (2)

Lead Sponsor	Collaborator
Universita di Verona	National University of Ireland, Galway, Ireland

Country where clinical trial is conducted

Italy, 

References & Publications (1)

Pighi M, Lunardi M, Pesarini G, Castriota F, Venturi G, Gottin L, Scarsini R, Ferrero V, Ribichini FL. Intravascular ultrasound assessment of coronary ostia following valve-in-valve transcatheter aortic valve implantation. EuroIntervention. 2021 Feb 19;16(14):1148-1151. doi: 10.4244/EIJ-D-20-00611. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of IVUS assessement success	Feasibility of IVUS assessement after the valve implantation (Yes, No)	Within the same 1 procedural day
Primary	Incidence of IVUS assessment-related adverse events	Safety of IVUS assessement. Composite of any clinical complication related to the attempted insertion of the IVUS catheter into the coronary artery, including: dissection, perforation, thrombosis, or flow impairment of the at-risk coronary or damage to the aortic wall or the THV during insertion of the IVUS catheter prior to or after TAVI.	Within the same 1 procedural day
Secondary	CHIMNEY stenting rate	Comparison between the actual rate of CHIMNEY stenting performed after the final IVUS assessment, and the rate of potential CHIMNEY stenting reported by operators on the only basis of CT and angiography images (before IVUS assessment). This will provide information about the number of stents that could be "spared" because deemed useless after the more accurate IVUS study	Within the same 1 procedural day
Secondary	MACE	Major Adverse Cardiovascular Events (MACE) occurred among patients treated with CHIMNEY stenting or with a deferred stent strategy at discharge, 30-day and 1-year follow-up	1 month, 1 year.
Secondary	IVUS-angiography agreement rate	The rate of agreement between angiography and IVUS evaluation of coronary ostia: rate of significant ostial stenosis as per angiography (%DS > 70 for RCA and > 50 for LM) vs IVUS assessment (lumen area < 4 mm2 for RCA and < 6 mm2 for LM).; rate of leaflet footprint/floating mass detection by angiography vs IVUS	Procedural 1 day
Secondary	Stent-optimization rate	The rate of stent optimization (post-dilatation or adjunctive stents) guided by IVUS assessment (only in stented coronaries)	Procedural 1 day